Navigation Links
Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
Date:2/22/2010

LAIYANG, China, Feb. 22 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) ("Jiangbo" or the "Company"), a pharmaceutical company with its principal operations in the People's Republic of China, today announced its financial results for the second quarter of its fiscal year 2010 ended December 31, 2009.

    Second Quarter Highlights and Recent Events

    -- Revenue was $18.2 million, a decrease of 44.8% from the corresponding
       quarter ended December 31, 2008
    -- Gross profit was $13.5 million, compared to $25.8 million for the
       corresponding quarter ended December 31, 2008, and gross margin was
       74.3%, compared to 78.3% in the a year ago quarter ended December 31,
       2008
    -- Operating income was $7.1 million, down 37.4% from the corresponding
       quarter ended December 31, 2008
    -- Net income was $5.3 million, or $0.49 per basic share, compared $5.4
       million or $0.55 per basic share a year ago
    -- Excluding non-cash gains related to the change in fair value from
       derivative liabilities of $6.7 million and the amortization of debt
       discount and debt issuance costs related to convertible debentures of
       $5.8 million, non-GAAP adjusted net income was $4.4 million, or $0.29
       per fully diluted share for the three months ended December 31, 2009,
       compared to non-GAAP adjusted net income of $6.6 million,
'/>"/>
SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
2. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
3. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
4. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
5. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... NEW YORK , June 3, 2015 ... grow at a CAGR of 10.1% from 2014 to ... market is driven by factors, such as the rising ... and growing technology advancements. However, factors such as lack ... the growth of this market. In ...
(Date:6/3/2015)... 3, 2015  Diomics today announced that Stephen ... has joined the company,s board of directors, effective immediately. ... Project and Clinical Professor at the Lyndon B. Johnson ... at Austin. "Steve brings an incredible ... years as a member of CIA,s clandestine service, including ...
(Date:6/3/2015)... DUBLIN , June 3, 2015  Actavis plc (NYSE: ... that Brent Saunders , CEO and President of Actavis, ... at the Goldman Sachs 36th Annual Global Healthcare Conference in ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO The presentation ... a.m. Pacific Time at the Terranea Resort, Rancho ...
Breaking Medicine Technology:Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 2Dermatology Treatment Devices Market by Type, by Application - Global Forecast to 2019 3Former CIA Clandestine Service Senior Official Stephen B. Slick joins Diomics Board of Directors 2Actavis to Present at the Goldman Sachs 36th Annual Global Healthcare Conference 2
... Serina Therapeutics, Inc. President and CEO Randall Moreadith, MD, PhD, ... financing round to advance its lead oncology candidate SER-203 into ... "We are pleased to report to our existing and ... launched in late 2010. This is a very significant milestone ...
... (Nasdaq: ENDP ) today announced that Alan Levin, ... corporate overview at the Goldman Sachs Global Healthcare Conference on ... will be held at the Terranea Resort in Rancho Palos ... of the presentation will be available on the company,s website ...
Cached Medicine Technology:Serina Therapeutics, Inc. Closes $9.5 Million Financing Round 2
(Date:6/3/2015)... The Bay Pines VA Healthcare System (VAHCS) will hold ... (VHA) National Women Veterans Campaign on June 12. The event ... the first floor of the C.W. Bill Young VA Medical ... and their families, Veteran Service Organizations, other stakeholders, and the ... event flyer, click here. , The event will showcase various ...
(Date:6/3/2015)... 2015 blingsting announces their new product, ... glove compartment or can be strapped onto a visor. ... a pointed tip that will allow the user to ... that can cut through a seatbelt or carseat strap ... include:, ,         Easily break a window or ...
(Date:6/3/2015)... June 03, 2015 As of 2014, ... information systems marketplace. Its share in the Asian market ... player. The market in this country is forecast to ... 2019, while the Asian market is expected to grow ... period. , Some of key factors encouraging growth of ...
(Date:6/3/2015)... Accountable care organizations (ACOs) are increasingly ... initial worries that these product types were too similar ... indicate that product-based ACOs will continue to grow in ... the June issue of Atlantic Information Services, Inc.’s (AIS) ... anecdotally that the backlash from HMOs seems to be ...
(Date:6/3/2015)... June 03, 2015 A recent ... precautions on product labels underscores the importance of ... to the American Society for Dermatologic Surgery Association. ... new warnings about the risks for serious injury ... While product labels already include information about risks, ...
Breaking Medicine News(10 mins):Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 2Health News:Bay Pines to Host National Women Veterans Campaign Event June 12 3Health News:blingsting Announces All New Car Safety Tool The Glammer 2Health News:Asian Pharmacy Information Systems Market to Grow at a 8.3% CAGR through 2019, Says MicroMarketMonitor in its New Report Available at MarketPublishers.com 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 2Health News:Product-Based ACOs Are Poised for Growth, Industry Observers Tell AIS Newsletter 3Health News:ASDSA Supports FDA Fillers Directive 2Health News:ASDSA Supports FDA Fillers Directive 3Health News:ASDSA Supports FDA Fillers Directive 4
... , FRIDAY, Nov. 9 (HealthDay News) -- A drug called ... patients with chronic active gout. , That,s according to a ... who had gout for an average of 13 years. , ... VA Medical Center and University of California, San Diego. , ...
... robots.,It sounds like the theme of a cartoon ... and innovative research being conducted at the University ... cognitive,development of infants with special needs., Two ... professor of,physical therapy, and Sunil Agrawal, professor of ...
... Nov. 9 World Diabetes Day is,November 14, ... celebrating the,successful launch of the 12-Day Stopping Diabetes ... treatments for type 2 diabetes, this,program focuses on ... its patients. Dr. Stuart Seale, medical director ...
... Washington, DC November 9, 2007 Shire plc ... biopharmaceutical company, yesterday announced results of a national survey ... to12 year old childs once-daily Attention Deficit Hyperactivity Disorder ... survey findings report the perceptions of 500 parents of ...
... DAKAR, Senegal -- The National Academy of Sciences and ... of the African Science Academy Development Initiative (ASADI), a ... to provide their nations with evidence-based advice. The ... the value of this advice in informing decisions about ...
... Bulletin Board:,NTRZ), a health science company and a ... that it will release its third quarter financial,results ... Management will host the conference call on ... 2007 third quarter financial results and provide,management updates. ...
Cached Medicine News:Health News:Babies Driving Robots at University 2Health News:Babies Driving Robots at University 3Health News:Babies Driving Robots at University 4Health News:Babies Driving Robots at University 5Health News:Babies Driving Robots at University 6Health News:New Sedona Stopping Diabetes Program 2Health News:Parents survey: Perceptions of the duration of their child's ADHD medication 2Health News:Safe water is theme of African science academies conference in Senegal 2Health News:NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14 2
... Prep Pads prepares the skin for improved ... dry, it leaves a thin film on ... surface and a barrier for natural body ... a dressing or tape. Skin Protectant is ...
... 70% USP and 10% Acetone Alcohol Prep ... antiseptic, anti-infective prior to administering injections. Acetone ... and fats from the skin. They are ... to contain a consistent amount of alcohol ...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Medicine Products: